These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
401 related items for PubMed ID: 29572114
1. Renal outcomes with sodium glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin, in obese insulin-resistant model. Jaikumkao K, Pongchaidecha A, Chueakula N, Thongnak L, Wanchai K, Chatsudthipong V, Chattipakorn N, Lungkaphin A. Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2021-2033. PubMed ID: 29572114 [Abstract] [Full Text] [Related]
2. SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats. Sa-Nguanmoo P, Tanajak P, Kerdphoo S, Jaiwongkam T, Pratchayasakul W, Chattipakorn N, Chattipakorn SC. Toxicol Appl Pharmacol; 2017 Oct 15; 333():43-50. PubMed ID: 28807765 [Abstract] [Full Text] [Related]
6. The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice. Wang D, Luo Y, Wang X, Orlicky DJ, Myakala K, Yang P, Levi M. Int J Mol Sci; 2018 Jan 03; 19(1):. PubMed ID: 29301371 [Abstract] [Full Text] [Related]
7. Dapagliflozin not only improves hepatic injury and pancreatic endoplasmic reticulum stress, but also induces hepatic gluconeogenic enzymes expression in obese rats. Swe MT, Thongnak L, Jaikumkao K, Pongchaidecha A, Chatsudthipong V, Lungkaphin A. Clin Sci (Lond); 2019 Dec 12; 133(23):2415-2430. PubMed ID: 31769484 [Abstract] [Full Text] [Related]
8. Atorvastatin attenuates obese-induced kidney injury and impaired renal organic anion transporter 3 function through inhibition of oxidative stress and inflammation. Pengrattanachot N, Cherngwelling R, Jaikumkao K, Pongchaidecha A, Thongnak L, Swe MT, Chatsudthipong V, Lungkaphin A. Biochim Biophys Acta Mol Basis Dis; 2020 Jun 01; 1866(6):165741. PubMed ID: 32101757 [Abstract] [Full Text] [Related]
9. Metformin mitigates renal dysfunction in obese insulin-resistant rats via activation of the AMPK/PPARα pathway. Thongnak L, Pengrattanachot N, Promsan S, Phengpol N, Sutthasupha P, Jaikumkao K, Lungkaphin A. Arch Pharm Res; 2023 May 01; 46(5):408-422. PubMed ID: 36966452 [Abstract] [Full Text] [Related]
14. Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes. Shin SJ, Chung S, Kim SJ, Lee EM, Yoo YH, Kim JW, Ahn YB, Kim ES, Moon SD, Kim MJ, Ko SH. PLoS One; 2016 Jul 31; 11(11):e0165703. PubMed ID: 27802313 [Abstract] [Full Text] [Related]
15. Fructooligosaccharides Ameliorate Renal Injury and Dysfunction Through the Modulation of Gut Dysbiosis, Inhibition of Renal Inflammation, Oxidative Stress, Fibrosis, and Improve Organic Anion Transporter 3 Function in an Obese Rat Model. Pengrattanachot N, Thongnak L, Promsan S, Phengpol N, Sutthasupha P, Tocharus J, Lungkaphin A. Mol Nutr Food Res; 2024 Aug 31; 68(16):e2400191. PubMed ID: 39021322 [Abstract] [Full Text] [Related]
16. Renal protective effect of SGLT2 inhibitor dapagliflozin alone and in combination with irbesartan in a rat model of diabetic nephropathy. Abdel-Wahab AF, Bamagous GA, Al-Harizy RM, ElSawy NA, Shahzad N, Ibrahim IA, Ghamdi SSA. Biomed Pharmacother; 2018 Jul 31; 103():59-66. PubMed ID: 29635129 [Abstract] [Full Text] [Related]
17. Organic anion transporter OAT3 enhances the glucosuric effect of the SGLT2 inhibitor empagliflozin. Fu Y, Breljak D, Onishi A, Batz F, Patel R, Huang W, Song P, Freeman B, Mayoux E, Koepsell H, Anzai N, Nigam SK, Sabolic I, Vallon V. Am J Physiol Renal Physiol; 2018 Aug 01; 315(2):F386-F394. PubMed ID: 29412698 [Abstract] [Full Text] [Related]
18. Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury. Tanajak P, Sa-Nguanmoo P, Sivasinprasasn S, Thummasorn S, Siri-Angkul N, Chattipakorn SC, Chattipakorn N. J Endocrinol; 2018 Feb 01; 236(2):69-84. PubMed ID: 29142025 [Abstract] [Full Text] [Related]
19. Prebiotic prevents impaired kidney and renal Oat3 functions in obese rats. Wanchai K, Yasom S, Tunapong W, Chunchai T, Thiennimitr P, Chaiyasut C, Pongchaidecha A, Chatsudthipong V, Chattipakorn S, Chattipakorn N, Lungkaphin A. J Endocrinol; 2018 Apr 01; 237(1):29-42. PubMed ID: 29483238 [Abstract] [Full Text] [Related]
20. Dapagliflozin and xanthine oxidase inhibitors improve insulin resistance and modulate renal glucose and urate transport in metabolic syndrome. Ng HY, Leung FF, Kuo WH, Lee WC, Lee CT. Clin Exp Pharmacol Physiol; 2021 Dec 01; 48(12):1603-1612. PubMed ID: 34407232 [Abstract] [Full Text] [Related] Page: [Next] [New Search]